Trial Profile
A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Clinical Study to Evaluate the Safety and Efficacy of PENNSAID Gel in the Symptomatic Treatment of Osteoarthritis of the Knee.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Oct 2019
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Mallinckrodt Inc.
- 03 May 2014 Results presented at the 33rd Annual Scientific Meeting of the American Pain Society.
- 16 Mar 2013 Status changed from active, no longer recruiting to completed.
- 30 Jun 2011 Primary endpoint 'Western-Ontario-and-McMaster-Universities-Osteoarthritis-Index - pain score' has been met.